ATE493993T1 - Chromanol glucoside zur verbesserung der chemischen krebsbehandlung - Google Patents

Chromanol glucoside zur verbesserung der chemischen krebsbehandlung

Info

Publication number
ATE493993T1
ATE493993T1 AT02707164T AT02707164T ATE493993T1 AT E493993 T1 ATE493993 T1 AT E493993T1 AT 02707164 T AT02707164 T AT 02707164T AT 02707164 T AT02707164 T AT 02707164T AT E493993 T1 ATE493993 T1 AT E493993T1
Authority
AT
Austria
Prior art keywords
cancer chemotherapy
hydrogen atom
alkyl group
lower alkyl
cancer treatment
Prior art date
Application number
AT02707164T
Other languages
English (en)
Inventor
Tsutomu Kagiya
Hironobu Murase
Nina Petrovna Konovalova
Ludmila Mihailovna Volkova
Nataliya Yurievna Lugovskaya
Lubov Sergeevna Vasilieva
Original Assignee
Tsutomu Kagiya
Cci Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsutomu Kagiya, Cci Corp filed Critical Tsutomu Kagiya
Application granted granted Critical
Publication of ATE493993T1 publication Critical patent/ATE493993T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
AT02707164T 2002-03-26 2002-03-26 Chromanol glucoside zur verbesserung der chemischen krebsbehandlung ATE493993T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2002/002914 WO2003080075A1 (fr) 2002-03-26 2002-03-26 Ameliorant pour le traitement chimique du cancer

Publications (1)

Publication Number Publication Date
ATE493993T1 true ATE493993T1 (de) 2011-01-15

Family

ID=28080696

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02707164T ATE493993T1 (de) 2002-03-26 2002-03-26 Chromanol glucoside zur verbesserung der chemischen krebsbehandlung

Country Status (7)

Country Link
US (1) US7462601B2 (de)
EP (1) EP1488796B1 (de)
JP (1) JP4509574B2 (de)
AT (1) ATE493993T1 (de)
DE (1) DE60238874D1 (de)
EA (1) EA009082B1 (de)
WO (1) WO2003080075A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070260550A1 (en) * 2006-04-20 2007-11-08 Tobid Pieper Digital goods export control
WO2017074211A1 (en) 2015-10-29 2017-05-04 Dmitry Dmitrievich Genkin Method to improve safety and efficacy of anti-cancer therapy

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0739000B2 (ja) * 1987-11-24 1995-05-01 株式会社明電舎 沈澱池の排泥制御装置
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP3550412B2 (ja) * 1993-02-10 2004-08-04 シーシーアイ株式会社 新規なクロマノール配糖体およびその製造方法
FR2741534B1 (fr) 1995-11-23 1998-09-11 Mazal Pharma Composition pharmaceutique stable a base d'acide acetylsalicylique et de tocopherol
JP3809679B2 (ja) 1996-01-11 2006-08-16 シーシーアイ株式会社 クロマノール配糖体およびその製造方法、並びにそれを用いた抗酸化剤
JPH1036260A (ja) 1996-07-18 1998-02-10 Mitsui Norin Kk 抗ガン剤の効力増強方法
JP4027448B2 (ja) 1996-08-30 2007-12-26 シーシーアイ株式会社 放射線防護剤
JPH10168095A (ja) * 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
CN1261803A (zh) * 1997-07-01 2000-08-02 埃瑟若詹尼克斯公司 抗氧化剂增强对细胞过度增生性疾病的治疗
JP3861949B2 (ja) 1997-07-01 2006-12-27 シーシーアイ株式会社 クロマノール配糖体およびその製造方法
JP2903465B2 (ja) * 1997-07-16 1999-06-07 末綱 陽子 新規なペプチドおよび活性化酸素阻害剤
EP1174140B1 (de) * 1999-03-31 2009-11-11 Cci Corporation Chromanol glycoside zur behandlung von durch ultraviolettes licht verursachten dermopathien
JP2001261563A (ja) * 2000-03-16 2001-09-26 Cci Corp マトリックスメタロプロテアーゼ産生抑制剤

Also Published As

Publication number Publication date
WO2003080075A1 (fr) 2003-10-02
EA009082B1 (ru) 2007-10-26
EP1488796A1 (de) 2004-12-22
EP1488796A4 (de) 2008-02-13
EP1488796B1 (de) 2011-01-05
US7462601B2 (en) 2008-12-09
DE60238874D1 (de) 2011-02-17
US20050215492A1 (en) 2005-09-29
EA200400968A1 (ru) 2005-04-28
JP4509574B2 (ja) 2010-07-21
JPWO2003080075A1 (ja) 2005-07-21

Similar Documents

Publication Publication Date Title
MX337751B (es) Sacaridos modificados.
ATE287288T1 (de) Hydrophobisch modifizierte saccharid-tenside
NZ577916A (en) Cyclopamine analogs
AU4114601A (en) Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
MA27769A1 (fr) Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique
ATE409048T1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
UA96152C2 (en) Dihydropyrazolopyrimidinone derivatives
TW200612920A (en) Novel imidazolidine derivatives
TNSN05017A1 (fr) Nouveaux composes gem difluores, leurs procedes de preparation et leurs applications
TNSN05197A1 (en) Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation -and immunologically- mediated diseases
BRPI0406646A (pt) Compostos de(2-carboxamido)(3-amina)tiofenos, bem como composições e usos compreendendo os mesmos
ATE361928T1 (de) Saccharid-alkylenoxyderivate und tinte
TW200833641A (en) Polyacetylenic compounds
MX2007002531A (es) Derivados novedosos de 3,5-seco-4-norcolestan y usos de los mismos.
CA2274575A1 (en) Preventive and curative agent for inflammatory bowel diseases
ATE493993T1 (de) Chromanol glucoside zur verbesserung der chemischen krebsbehandlung
EP1380595A4 (de) Verzweigtes cyclisches tetrasaccharid, verfahren zu seiner herstellung und verwendung
WO2008068429A3 (fr) Composition pour la prevention et/ou le traitement des maladies associees a la surexpression du tnf et/ou de l'il-12
BRPI0409264A (pt) composição cosmética de dois polissacarìdeos à base de fucose e de ramnose
EP1849467A4 (de) Synergistisch pharmazeutische zusammensetzung von baicalein und baicalin zur tumorhemmung
MX2012008389A (es) Metodos para producir compuestos glicolipidos sustituidos con aminas.
de Almeida et al. Synthesis of amphiphilic galactopyranosyl diamines and amino alcohols as antitubercular agents
TW200806334A (en) Skin cosmetic
DE602007007218D1 (de) Neue zuckerderivate, verfahren für ihre zubereitung und ihre verwendung als oberflächenaktive mittel
WO2004014959A3 (fr) Derives de cyclodextrines, leur procede de preparation et leurs applications

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties